Inventor
Dan Wang
Inventor
Kanata, CA
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
B01LChemical or physical laboratory apparatus for general use13%
C07KPeptides10%
C12NMicroorganisms or enzymes10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C07CAcyclic or carbocyclic compounds6%
C07DHeterocyclic compounds6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
A61KPreparations for medical, dental or toiletry purposes3%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
10,851,393KAS-III free FA synthesis202010,774,349Alpha omega bifunctional fatty acids202010,760,092Polypeptide and use thereof for improving stress tolerance in plants202010,746,749Ellagic acid formulations for use in coagulation assays202010,710,886Methods for synthesizing mesoporous zeolite ETS-10 containing metal without a templating agent202010,584,321Compositions and methods for transient delivery of nucleases20209,921,232'Ellagic acid formulations for use in coagulation assays'20189,670,538'Nucleic acid sequencing by electrochemical detection'20179,617,256'Antibacterial agents'20179,575,076'TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats'20179,575,077'TSH antibodies for point-of-care immunoassay formats'20179,562,874'Biosensor with improved interference characteristics'20179,493,812'Method for detecting a target analyte that exhibits protease enzyme activity'20169,421,269'Saponin nano micelle, preparing method, application and pharmaceutical composition thereof'20169,249,450'Glutamate oxidase mutagenesis for diagnostic testing'20169,201,078'TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats'20159,199,234'TSH antibodies for point-of-care immunoassay formats'20156,593,327'Compounds and compositions as protease inhibitors'20036,525,036'Compounds and compositions as protease inhibitors'20036,476,026'Compounds and compositions as protease inhibitors'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2003Patents assigned to AXYS PHARM INC (2)· patent assignee history
2002–2003Based in Foster City, CA, US· patent location history
2015–2020Patents assigned to ABBOTT POINT OF CARE INC (9)· patent assignee history
2015–2017Patents assigned to COLLIER GORDON BRUCE (3)· patent assignee history
2015–2017Patents assigned to WANG DAN (3)· patent assignee history
2015Patents assigned to RUAN QIAOQIAO (2)· patent assignee history
2015–2020Based in Kanata, CA· patent location history
2020Based in Houston, TX, US· patent location history
2020Based in Tianjin, CN· patent location history
2020Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT POINT OF CARE INC | 9 | 2015–2020 |
| COLLIER GORDON BRUCE | 3 | 2015–2017 |
| WANG DANself | 3 | 2015–2017 |
| AXYS PHARM INC | 2 | 2002–2003 |
| RUAN QIAOQIAO | 2 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kanata, CA | 9 | 2015–2020 |
| Foster City, California, US | 3 | 2002–2003 |
| Houston, Texas, US | 2 | 2020 |
| Tianjin, CN | 1 | 2020 |
| Beijing, CN | 1 | 2020 |